Showing results (1-10 of 76) with videos related to
Sort By:
Pageof 8
Current Opinion in Chemical Biology|September 14, 2007
Fragment-based screening using X-ray crystallography and NMR spectroscopyHarren Jhoti, Anne Cleasby, Marcel Verdonk, et al.Chembiochem : a European Journal of Chemical Biology|February 8, 2005
The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallographyAdrian Gill, Anne Cleasby, Harren JhotiJournal of Medicinal Chemistry|January 22, 2005
Fragment-based lead discovery using X-ray crystallographyMichael J Hartshorn, Christopher W Murray, Anne Cleasby, et al.Drug Discovery Today|May 2, 2002
Structure-based screening of low-affinity compoundsRobin Carr, Harren JhotiCurrent Opinion in Chemical Biology|June 27, 2003
High-throughput crystallography to enhance drug discoveryAndrew Sharff, Harren JhotiDrug Discovery Today|March 18, 2019
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug designMarc O'Reilly, Anne Cleasby, Thomas G Davies, et al.Expert Opinion on Drug Discovery|November 12, 2013
High-throughput screening and structure-based approaches to hit discovery: is there a clear winner?Harren Jhoti, Stephen Rees, Roberto SolariNature Reviews. Drug Discovery|July 18, 2002
High-throughput crystallography for lead discovery in drug designTom L Blundell, Harren Jhoti, Chris AbellProceedings of the National Academy of Sciences of the United States of America|February 25, 2009
Crystal structure of human CDK4 in complex with a D-type cyclinPhilip J Day, Anne Cleasby, Ian J Tickle, et al.Biochemical Society Transactions|January 28, 2020
Fragments: where are we now?James Osborne, Stanislava Panova, Magdalini Rapti, et al.Pageof 8